Medtronic PLC (MDT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $131.60B
Last updated: Nov 17, 2026 at 4:33 PM ET
Medtronic PLC (MDT) Statistics
Medtronic (MDT) has a market cap of $131.60B and an enterprise value of $158.06B. Its trailing P/E is 17.9x.
Total Valuation
Enterprise value is 20.11% above the market cap, as debt exceeds cash.
| Market Cap | $131.60B |
|---|---|
| Enterprise Value | $158.06B |
| Latest price (Nov 17, 2026) | $102.28 |
Key Dates
The next earnings report is set for Nov 24, 2026, before the open. The last ex-dividend date was Sep 25, 2026.
| Next Earnings Date | Nov 24, 2026, before the open |
|---|---|
| Last Earnings Date | Sep 1, 2026 |
| Last Ex-Dividend Date | Sep 25, 2026 |
| Last Payment Date | Oct 16, 2026 |
| Fiscal Year End | April |
Valuation Ratios
Sales and book value multiples are 3.5x and 2.6x. Its year-end P/E ranged from 14.6x to 32.0x from 2016 to 2025.
| P/E Ratio | 17.9x |
|---|---|
| Forward P/E | 16.9x |
| P/S Ratio | 3.5x |
| Forward P/S | 3.4x |
| P/B Ratio | 2.6x |
| P/FCF Ratio | 21.3x |
| P/OCF Ratio | 16.4x |
| PEG Ratio | 2.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.3x EBITDA and 25.7x free cash flow.
| EV / Earnings | 30.0x |
|---|---|
| EV / Sales | 4.2x |
| EV / EBITDA | 15.3x |
| EV / EBIT | 21.6x |
| EV / FCF | 25.7x |
Price Statistics
The stock is up 8.35% over 52 weeks and trades 8.90% above its 50-day average.
| Beta (1Y) | 0.16 |
|---|---|
| 52-Week Change | +8.35% |
| 1-Month Change | +10.25% |
| 3-Month Change | +9.54% |
| 6-Month Change | +32.38% |
| 5-Year Change | -19.46% |
| 10-Year Change | +17.70% |
| Total Return (1Y) | +11.38% |
| Total Return (3Y CAGR) | +13.46% |
| Total Return (5Y CAGR) | -0.26% |
| Return vs SPY (1Y) | -8.51% |
| Max Drawdown (1Y) | -30.10% |
| Max Drawdown (3Y) | -30.10% |
| Sharpe Ratio (1Y) | 0.12 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $93.92 |
| 200-Day Average | $87.41 |
| 52-Week Range | $72.06 to $106.20 |
| RSI (14 Days) | 61.7 |
| Average Volume (20 Days) | 7.64M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.07x current liabilities, and total debt is 0.56x shareholder equity.
| Current Ratio | 2.07x |
|---|---|
| Quick Ratio | 1.54x |
| Debt / Equity | 0.56x |
| Debt / EBITDA | 2.74x |
| Debt / FCF | 4.59x |
| Interest Coverage | 10.11x |
Returns and Efficiency
Return on invested capital is 7.46% over the last 12 months, against a 5-year average of 6.48%.
| Return on Equity (ROE) | 10.49% |
|---|---|
| Return on Assets (ROA) | 5.65% |
| Return on Invested Capital (ROIC) | 7.46% |
| Return on Capital Employed (ROCE) | 8.99% |
| ROE (5Y Average) | 8.78% |
| ROA (5Y Average) | 4.83% |
| ROIC (5Y Average) | 6.48% |
| Asset Turnover | 0.41x |
| Inventory Turnover | 2.16x |
| Receivables Turnover | 5.78x |
| Cash Conversion Cycle | 158 days |
Taxes
Income tax took 20.19% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.33B |
|---|---|
| Effective Tax Rate | 20.19% |
Scores
MDT has an Altman Z-Score of 3.17, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.17 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $37.54B over the last 12 months is up 9.77% from the 12 months before.
| Revenue | $37.54B |
|---|---|
| Revenue Growth (YoY) | +9.77% |
| Gross Profit | $24.41B |
| Operating Income | $6.79B |
| Pretax Income | $6.60B |
| Net Income | $5.27B |
| EBITDA | $10.27B |
| EBIT | $7.33B |
| Reported EPS (TTM) | $5.72 |
Trailing 12 months through Jul 31, 2026.
Balance Sheet
Shareholder equity funds 53.83% of the $93.31B in total assets.
| Cash and Equivalents | $1.69B |
|---|---|
| Total Debt | $28.15B |
| Net Debt | $26.46B |
| Net Debt Per Share | $20.68 |
| Working Capital | $12.59B |
| Shareholder Equity | $50.23B |
| Book Value Per Share | $39.25 |
| Tangible Book Value | -$3.19B |
| Total Assets | $93.31B |
| Total Liabilities | $42.46B |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $1.90B of capital spending, operating cash flow left $6.13B of free cash flow.
| Operating Cash Flow | $8.04B |
|---|---|
| Capital Expenditures | $1.90B |
| Free Cash Flow | $6.13B |
| FCF Per Share | $4.79 |
| Depreciation and Amortization | $2.94B |
| Dividends Paid | $3.65B |
| Share Repurchases | $1.18B |
Trailing 12 months through Jul 31, 2026.
Margins
The operating margin is 18.08%, against a 5-year average of 17.43%.
| Gross Margin | 65.01% |
|---|---|
| Operating Margin | 18.08% |
| Pretax Margin | 17.59% |
| Net Margin | 14.03% |
| EBITDA Margin | 27.35% |
| EBIT Margin | 19.52% |
| FCF Margin | 16.33% |
| Gross Margin (5Y Average) | 65.87% |
| Operating Margin (5Y Average) | 17.43% |
| Net Margin (5Y Average) | 13.37% |
Growth
Revenue grew 5.21% a year over 3 years, and EPS 1.43% a year.
| Revenue Growth (3Y CAGR) | +5.21% |
|---|---|
| Revenue Growth (5Y CAGR) | +3.84% |
| EPS Growth (3Y CAGR) | +1.43% |
| EPS Growth (5Y CAGR) | +4.54% |
| FCF Growth (3Y CAGR) | +5.81% |
| FCF Growth (5Y CAGR) | +2.12% |
| Operating Income Growth (3Y CAGR) | +5.64% |
| Book Value Per Share Growth (2Y CAGR) | +0.68% |
Dividends and Yields
MDT pays out 45.55% of earnings as dividends.
| Dividend Per Share (Annual) | $2.88 |
|---|---|
| Dividend Yield | 2.82% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +1.96% |
| Dividend Growth (5Y CAGR) | +4.42% |
| Payout Ratio | 45.55% |
| FCF Payout Ratio | 59.52% |
| Earnings Yield | 5.59% |
| FCF Yield | 4.68% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 2.94% |
Stock Splits
The last split was a 2-for-1 forward split on Sep 27, 1999.
| Last Split Date | Sep 27, 1999 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 11 similar companies, MDT has the 8th highest P/E.
P/E RatioPeer median 22.2x
P/S RatioPeer median 3.6x
ROICPeer median 8.43%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.50%
Dividend YieldPeer median 0.10%
| P/E Ratio | 17.9x vs 22.2x median |
|---|---|
| P/S Ratio | 3.5x vs 3.6x median |
| ROIC | 7.46% vs 8.43% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +9.77% vs +8.50% median |
| Dividend Yield | 2.82% vs 0.10% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.41% and EPS growth at 7.63% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.41% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +7.63% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MDT
What is MDT's market cap?
Medtronic has a market cap of $131.60B. Its enterprise value, which adds debt and subtracts cash, is $158.06B.
What is MDT's P/E ratio?
Medtronic has a trailing P/E ratio of 17.9x and a forward P/E of 16.9x.
How many shares of MDT are outstanding?
Medtronic has 1.28B shares outstanding. The count is down 0.14% from a year earlier.
Does MDT pay a dividend?
Yes. Medtronic pays $2.88 a share a year, a dividend yield of 2.82%.
How much debt does MDT have?
Medtronic has $28.15B of total debt and $1.69B of cash and equivalents, a net debt position of $26.46B.
MDT pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts